2020 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
2019 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
2011 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Total number of projects: 8
As coordinator: 3
As participant: 5
Sole participant: 0
Coordinator / Participant Ratio: 0.6*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2021 | 0 | 18.600.000 | 432.058 | 1 | ||
2020 | 0 | 1.879.216 | 54.375 | 1 | ||
2019 | 6.871.189 | 2.701.874 | 1.152.312 | 1 | 1 | |
2017 | 0 | 10.599.993 | 75.320 | 1 | ||
2016 | 8.553.750 | 0 | 1.625.000 | 1 | ||
2013 | 0 | 496.367 | 212.500 | 1 | ||
2011 | 29.980.670 | 0 | 5.052.094 | 1 |
Total number of partners: 174
Partner loyalty:
Frequent Partner: (> 2 projects): 33
Rare Partner: 141
Frequent / Rare Partner Ratio: 0.23
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2021-09-01 | Innovations to accelerate vaccine development and manufacture | Inno4Vac | participant | 18.600.000 | 41 |
2020-06-01 | DESIGN STUDY FOR A EUROPEAN VACCINE INFRASTRUCTURE | TRANSVAC-DS | participant | 1.879.216 | 28 |
2019-10-01 | Advancing a GMMA-based vaccine against invasive non-typhoidal salmonellosis through Phase 1 trial in Europe and sub-Saharan Africa | Vacc-iNTS | coordinator | 6.871.189 | 12 |
2019-01-01 | Novel vaccine vectors to resist pathogen challenge | VacPath | participant | 2.701.874 | 8 |
2017-05-01 | European Vaccine Research and Development Infrastructure | TRANSVAC2 | participant | 10.599.993 | 26 |
2016-04-01 | SYSTEMS ANALYSIS OF ADULT AND PEDIATRIC RESPONSES TO THE VSV-ZEBOV EBOLA VACCINE - Sofia ref.: 116068 | VSV-EBOPLUS | coordinator | 8.553.750 | 11 |
2013-12-01 | Innovation Partnership for a Roadmap on Vaccines in Europe | IPROVE | participant | 496.367 | 4 |
2011-10-01 | Advanced Immunization Technologies | ADITEC | coordinator | 29.980.670 | 52 |